| Year |
Citation |
Score |
| 2003 |
Gunawardane RN, Martin OC, Zheng Y. Characterization of a new gammaTuRC subunit with WD repeats. Molecular Biology of the Cell. 14: 1017-26. PMID 12631720 DOI: 10.1091/Mbc.E02-01-0034 |
0.71 |
|
| 2001 |
Gunawardane RN, Zheng Y, Oegema K, Wiese C. Purification and reconstitution of Drosophila gamma-tubulin complexes. Methods in Cell Biology. 67: 1-25. PMID 11550462 DOI: 10.1016/S0091-679X(01)67002-X |
0.649 |
|
| 2001 |
Gunawardane RN, Zheng Y, Oegema K, Wiese C. Purification and reconstitution of Drosophila γ-tubulin complexes Methods in Cell Biology. 1-25. |
0.562 |
|
| 2000 |
Gunawardane RN, Martin OC, Cao K, Zhang L, Dej K, Iwamatsu A, Zheng Y. Characterization and reconstitution of Drosophila gamma-tubulin ring complex subunits. The Journal of Cell Biology. 151: 1513-24. PMID 11134079 DOI: 10.1083/Jcb.151.7.1513 |
0.678 |
|
| 2000 |
Gunawardane RN, Lizarraga SB, Wiese C, Wilde A, Zheng Y. gamma-Tubulin complexes and their role in microtubule nucleation. Current Topics in Developmental Biology. 49: 55-73. PMID 11005014 DOI: 10.1016/S0070-2153(99)49004-0 |
0.565 |
|
| 1998 |
Martin OC, Gunawardane RN, Iwamatsu A, Zheng Y. Xgrip109: a gamma tubulin-associated protein with an essential role in gamma tubulin ring complex (gammaTuRC) assembly and centrosome function. The Journal of Cell Biology. 141: 675-87. PMID 9566968 DOI: 10.1083/Jcb.141.3.675 |
0.718 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Roberts B, Haupt A, Tucker A, Grancharova T, Arakaki J, Fuqua MA, Nelson A, Hookway C, Ludmann SA, Mueller IA, Yang R, Horwitz AR, Rafelski SM, Gunawardane RN. Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization. Molecular Biology of the Cell. PMID 28814507 DOI: 10.1091/mbc.E17-03-0209 |
0.241 |
|
| 2015 |
Piper DE, Romanow WG, Gunawardane RN, Fordstrom P, Masterman S, Pan O, Thibault ST, Zhang R, Meininger D, Schwarz M, Wang Z, King C, Zhou M, Walker NP. The high resolution crystal structure of human LCAT. Journal of Lipid Research. PMID 26195816 DOI: 10.1194/jlr.M059873 |
0.225 |
|
| 2018 |
Haupt A, Grancharova T, Arakaki J, Fuqua MA, Roberts B, Gunawardane RN. Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9. Journal of Visualized Experiments : Jove. PMID 30199041 DOI: 10.3791/58130 |
0.225 |
|
| 2023 |
Viana MP, Chen J, Knijnenburg TA, Vasan R, Yan C, Arakaki JE, Bailey M, Berry B, Borensztejn A, Brown EM, Carlson S, Cass JA, Chaudhuri B, Cordes Metzler KR, Coston ME, ... ... Gunawardane RN, et al. Integrated intracellular organization and its variations in human iPS cells. Nature. PMID 36599983 DOI: 10.1038/s41586-022-05563-7 |
0.215 |
|
| 2006 |
Witt AE, Hines LM, Collins NL, Hu Y, Gunawardane RN, Moreira D, Raphael J, Jepson D, Koundinya M, Rolfs A, Taron B, Isakoff SJ, Brugge JS, LaBaer J. Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. Journal of Proteome Research. 5: 599-610. PMID 16512675 DOI: 10.1021/Pr050395R |
0.197 |
|
| 2019 |
Roberts B, Hendershott MC, Arakaki J, Gerbin KA, Malik H, Nelson A, Gehring J, Hookway C, Ludmann SA, Yang R, Haupt A, Grancharova T, Valencia V, Fuqua MA, Tucker A, ... ... Gunawardane RN, et al. Fluorescent Gene Tagging of Transcriptionally Silent Genes in hiPSCs. Stem Cell Reports. PMID 30956114 DOI: 10.1016/j.stemcr.2019.03.001 |
0.153 |
|
| 2021 |
Gerbin KA, Grancharova T, Donovan-Maiye RM, Hendershott MC, Anderson HG, Brown JM, Chen J, Dinh SQ, Gehring JL, Johnson GR, Lee H, Nath A, Nelson AM, Sluzewski MF, Viana MP, ... ... Gunawardane RN, et al. Cell states beyond transcriptomics: Integrating structural organization and gene expression in hiPSC-derived cardiomyocytes. Cell Systems. PMID 34043964 DOI: 10.1016/j.cels.2021.05.001 |
0.15 |
|
| 2015 |
Gunawardane RN, Fordstrom P, Piper DE, Masterman S, Siu S, Liu D, Brown M, Lu M, Tang J, Zhang R, Cheng J, Gates A, Meininger D, Chan J, Carlson T, et al. Agonistic Human Antibodies Binding To Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism. The Journal of Biological Chemistry. PMID 26644477 DOI: 10.1074/jbc.M115.672790 |
0.137 |
|
| 2023 |
Gregor BW, Coston ME, Adams EM, Arakaki J, Borensztejn A, Do TP, Fuqua MA, Haupt A, Hendershott MC, Leung W, Mueller IA, Nath A, Nelson AM, Rafelski SM, Sanchez EE, ... ... Gunawardane RN, et al. Automated human induced pluripotent stem cell culture and sample preparation for 3D live-cell microscopy. Nature Protocols. PMID 38087082 DOI: 10.1038/s41596-023-00912-w |
0.132 |
|
| 2012 |
Rowbottom MW, Faraoni R, Chao Q, Campbell BT, Lai AG, Setti E, Ezawa M, Sprankle KG, Abraham S, Tran L, Struss B, Gibney M, Armstrong RC, Gunawardane RN, Nepomuceno RR, et al. Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600E. Journal of Medicinal Chemistry. 55: 1082-105. PMID 22168626 DOI: 10.1021/jm2009925 |
0.112 |
|
| 2012 |
Liu G, Abraham S, Tran L, Vickers TD, Xu S, Hadd MJ, Quiambao S, Holladay MW, Hua H, Ford Pulido JM, Gunawardane RN, Davis MI, Eichelberger SR, Apuy JL, Gitnick D, et al. Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic index. Journal of Medicinal Chemistry. 55: 3250-60. PMID 22380736 DOI: 10.1021/Jm201702G |
0.109 |
|
| 2023 |
Lee S, Roest ASV, Blair CA, Kao K, Bremner SB, Childers MC, Pathak D, Heinrich P, Lee D, Chirikian O, Mohran S, Roberts B, Smith JE, Jahng JW, Paik DT, ... ... Gunawardane RN, et al. Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respiration. Biorxiv : the Preprint Server For Biology. PMID 37333118 DOI: 10.1101/2023.06.08.544276 |
0.107 |
|
| 2010 |
Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, Meyer CA, Lightcap ES, Tamayo P, Mesirov JP, Liu XS, Shioda T, Toner M, Loda M, Brown M, et al. MYC regulation of a "poor-prognosis" metastatic cancer cell state. Proceedings of the National Academy of Sciences of the United States of America. 107: 3698-703. PMID 20133671 DOI: 10.1073/Pnas.0914203107 |
0.107 |
|
| 2005 |
Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS. Novel role for PDEF in epithelial cell migration and invasion. Cancer Research. 65: 11572-80. PMID 16357167 DOI: 10.1158/0008-5472.Can-05-1196 |
0.097 |
|
| 2012 |
James J, Ruggeri B, Armstrong RC, Rowbottom MW, Jones-Bolin S, Gunawardane RN, Dobrzanski P, Gardner MF, Zhao H, Cramer MD, Hunter K, Nepomuceno RR, Cheng M, Gitnick D, Yazdanian M, et al. CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity. Molecular Cancer Therapeutics. 11: 930-41. PMID 22319199 DOI: 10.1158/1535-7163.MCT-11-0645 |
0.093 |
|
| 2013 |
Gunawardane RN, Nepomuceno RR, Rooks AM, Hunt JP, Ricono JM, Belli B, Armstrong RC. Transient exposure to quizartinib mediates sustained inhibition of FLT3 signaling while specifically inducing apoptosis in FLT3-activated leukemia cells. Molecular Cancer Therapeutics. 12: 438-47. PMID 23412931 DOI: 10.1158/1535-7163.MCT-12-0305 |
0.092 |
|
| 2011 |
Holladay MW, Campbell BT, Rowbottom MW, Chao Q, Sprankle KG, Lai AG, Abraham S, Setti E, Faraoni R, Tran L, Armstrong RC, Gunawardane RN, Gardner MF, Cramer MD, Gitnick D, et al. 4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 5342-6. PMID 21807507 DOI: 10.1016/j.bmcl.2011.07.019 |
0.085 |
|
| 2008 |
Zarrinkar PP, Armstrong RC, Gunawardane RN, James J, Karaman MW, Bhagwat SS. AC220 Is a Uniquely Potent and Selective Second-Generation FLT3 Inhibitor Blood. 112: 859-859. DOI: 10.1182/blood.v112.11.859.859 |
0.06 |
|
| 2021 |
Grancharova T, Gerbin KA, Rosenberg AB, Roco CM, Arakaki JE, DeLizo CM, Dinh SQ, Donovan-Maiye RM, Hirano M, Nelson AM, Tang J, Theriot JA, Yan C, Menon V, Palecek SP, ... ... Gunawardane RN, et al. A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes. Scientific Reports. 11: 15845. PMID 34349150 DOI: 10.1038/s41598-021-94732-1 |
0.053 |
|
| 2011 |
Nepomuceno RR, Gunawardane R, Rooks AM, Armstrong RC. Detection of Phosphorylated and Total Flt3 and STAT5 in Whole Blood: Modulation by AC220 From Phase I and II Trials in AML Blood. 118: 2607-2607. DOI: 10.1182/blood.V118.21.2607.2607 |
0.051 |
|
| 2013 |
Buchwalter G, Hickey MM, Cromer A, Selfors LM, Gunawardane RN, Frishman J, Jeselsohn R, Lim E, Chi D, Fu X, Schiff R, Brown M, Brugge JS. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells. Cancer Cell. 23: 753-67. PMID 23764000 DOI: 10.1016/J.Ccr.2013.04.026 |
0.046 |
|
| 2009 |
Chao Q, Sprankle KG, Grotzfeld RM, Lai AG, Carter TA, Velasco AM, Gunawardane RN, Cramer MD, Gardner MF, James J, Zarrinkar PP, Patel HK, Bhagwat SS. Identification of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitor. Journal of Medicinal Chemistry. 52: 7808-16. PMID 19754199 DOI: 10.1021/Jm9007533 |
0.038 |
|
| 2021 |
Horwitz R, Riley EAU, Millan MT, Gunawardane RN. It's time to incorporate diversity into our basic science and disease models. Nature Cell Biology. 23: 1213-1214. PMID 34845353 DOI: 10.1038/s41556-021-00803-w |
0.037 |
|
| 2009 |
Cortes J, Foran J, Ghirdaladze D, DeVetten MP, Zodelava M, Holman P, Levis MJ, Kantarjian HM, Borthakur G, James J, Zarringkar PP, Gunawardane RN, Armstrong RC, Padre NM, Wierenga W, et al. AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study. Blood. 114: 636-636. DOI: 10.1182/blood.V114.22.636.636 |
0.027 |
|
| 2009 |
Zarrinkar PP, Gunawardane RN, Cramer MD, Gardner MF, Brigham D, Belli B, Karaman MW, Pratz KW, Pallares G, Chao Q, Sprankle KG, Patel HK, Levis M, Armstrong RC, James J, et al. AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood. 114: 2984-92. PMID 19654408 DOI: 10.1182/blood-2009-05-222034 |
0.011 |
|
| Hide low-probability matches. |